BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15837320)

  • 1. N-DEVD-N'-morpholinecarbonyl-rhodamine 110: novel caspase-3 fluorogenic substrates for cell-based apoptosis assay.
    Wang ZQ; Liao J; Diwu Z
    Bioorg Med Chem Lett; 2005 May; 15(9):2335-8. PubMed ID: 15837320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Ac-DEVD-N'-(Polyfluorobenzoyl)-R110: novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis.
    Zhang HZ; Kasibhatla S; Guastella J; Tseng B; Drewe J; Cai SX
    Bioconjug Chem; 2003; 14(2):458-63. PubMed ID: 12643757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay.
    Cai SX; Zhang HZ; Guastella J; Drewe J; Yang W; Weber E
    Bioorg Med Chem Lett; 2001 Jan; 11(1):39-42. PubMed ID: 11140728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morpholinecarbonyl-Rhodamine 110 based substrates for the determination of protease activity with accurate kinetic parameters.
    Terentyeva TG; Van Rossom W; Van der Auweraer M; Blank K; Hofkens J
    Bioconjug Chem; 2011 Oct; 22(10):1932-8. PubMed ID: 21905728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 131I-labeled peptides as caspase substrates for apoptosis imaging.
    Bauer C; Bauder-Wuest U; Mier W; Haberkorn U; Eisenhut M
    J Nucl Med; 2005 Jun; 46(6):1066-74. PubMed ID: 15937321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
    Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
    ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
    Pereira NA; Song Z
    Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide substrate for caspase-3 with 2-aminoacridone as reporting group.
    Lozanov V; Ivanov IP; Benkova B; Mitev V
    Amino Acids; 2009 Mar; 36(3):581-6. PubMed ID: 18597040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
    Fang B; Boross PI; Tozser J; Weber IT
    J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
    Agniswamy J; Fang B; Weber IT
    FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
    Goode DR; Sharma AK; Hergenrother PJ
    Org Lett; 2005 Aug; 7(16):3529-32. PubMed ID: 16048334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
    Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
    J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ; Ng LT; Lin CC
    Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The treatment of retinal apoptosis by Caspase 3 inhibitor Ac-DEVD-CHO in experimental myopia].
    Liu SZ; Mao JF; Wen D; Tan XP; Fu CY
    Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):428-33. PubMed ID: 15938808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3.
    Micale N; Vairagoundar R; Yakovlev AG; Kozikowski AP
    J Med Chem; 2004 Dec; 47(26):6455-8. PubMed ID: 15588079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant caspase specificity by competitive substrates.
    Benkova B; Lozanov V; Ivanov IP; Mitev V
    Anal Biochem; 2009 Nov; 394(1):68-74. PubMed ID: 19595985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inducement effect of Meisoindigo on apoptosis of leukemia cell line HL-60 and its mechanism].
    Wang Y; Zhu XF; Xiao ZJ; Wang HH; Zhou JM; Mei YP; Deng R; Jiang WQ; Liu ZC
    Ai Zheng; 2005 Dec; 24(12):1464-8. PubMed ID: 16351793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new fluorogenic substrate for microsomal glutathione transferase 1.
    Alander J; Johansson K; Heuser VD; Farebo H; Järvliden J; Abe H; Shibata A; Ito M; Ito Y; Morgenstern R
    Anal Biochem; 2009 Jul; 390(1):52-6. PubMed ID: 19348782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.